CDC Group has announced a $100 million investment in Helios Investor IV, a pan-African fund that will invest in market leading firms across the continent.
Helios Investor IV is the fourth private equity fund raised by Helios Investment Partners with the latest investment from CDC signaling confidence in the firm.
CDC head of Africa Funds, Clarisa De Franco, said
“Our investment will allow growing African companies to access much-needed finance to support their development and expansion at a particularly challenging time in the markets. CDC takes its direct foreign investment role seriously in ensuring trade and investing in African companies continues smoothly to enable a swift post-COVID-19 recovery”
Clarisa De Franco
Clarisa says that the investment will allow Helios to invest in promising companies, create lasting jobs, and accelerate progress towards sustainable development goals across the region.
Helios has offices in Nairobi and Lagos and has invested over $3bn in businesses operating in over 30 African countries since launching the first private equity fund in 2008. CDC Group is a development finance institution owned by the UK government. It is focused on the emerging markets of South Asia and Africa.
RELATED
CDC Partners With Rwanda Finance on Development of Kigali International Financial Center
CDC Group Appoints New Heads For Nairobi and Lagos Offices
CDC Loses KSh14 Billion Investment in ARM Cement
